Bielefeld, Germany
Puraite, founded in 2025, is a pioneering German startup that aims to revolutionize systematic literature reviews and evidence synthesis in the pharmaceutical and life sciences industries. As a spin-off from Paderborn University, the company's AI-driven solutions enhance efficiency in generating medical evidence necessary for drug development and health technology assessments.
The company stands out with its slogan, "Medical Evidence in real-time. Powered by AI." By leveraging sophisticated AI, Puraite automates key elements in the evidence pipeline, thus reducing time and costs significantly. This process is undergirded by over €1.1 million in non-dilutive public funding, demonstrating strong institutional support.
Notably, Puraite offers an explainable AI engine that assures regulatory standards through traceability and confidence scores, serving pharmaceutical companies and CROs in producing reliable evidence for drug development and market access. The company's hybrid human-in-the-loop model ensures both scientific validity and optimal resource allocation. Such innovation places Puraite in a compelling position for future investment opportunities.
